Authorisations of human medicines

Within the framework of the authorisation procedure, Swissmedic assesses the quality, safety and effectiveness of the medicinal product in question on the basis of the comprehensive scientific documentation that is submitted.

If the criteria for authorisation are fulfilled, Swissmedic grants the marketing authorisation, specifies the method of sale (on prescription only/dispensing point) and approves the information for healthcare professionals and the patient information.

Informations

Show all

18.06.2026

Revised annex 3a TPLRO

Polysorbates as excipients of particular interest

01.06.2026

Changes to the Project Orbis guidance document

Project Orbis guidance document updated